Posts

Showing posts from December, 2021

Staple Fibers Market Development Status, Competition Analysis, Type and Application 2026

Survey Conducted by Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Insights into Vital Dynamics Facilitating the Growth in the Global Staple Fibers   Market over the Assessment Period 2016–2026 A comprehensive study on Staple Fibers market by FMI provides insights into key factors and opportunities facilitating the growth in the market. The report conducts an in-depth analysis into factors affecting the change in consumer behavior and purchasing patterns.   The survey offers detailed insights into scope for expansion in developed and developing markets through 2026. As per the  r ecent research conducted by a leading market insights provider FMI, the global  Staple Fibers market  will expand at a healthy CAGR over the forecast period between 2016 and 2026. The aim of this study is to analyze key market dynamics affecting the sales of Staple Fibers and provide vital insights to business owners to get benefited...

Synthetic Camphor Market is expected to increase at a CAGR of 5.9% over the forecast period 2018–2028

  Pharma-grade synthetic camphor is extensively used in various topical analgesic products such as ointments, oils, gels, and chest-rubs. These pharma-grade synthetic camphor for topical pain management products are witnessing significant demand owing to consumer preference for self-medication, undergird by enhanced and easy accessibility of OTC products. According to the report, pharma-grade synthetic camphor is projected to account for more than 50% volume share in 2019 in the   synthetic camphor market . Pharma-grade synthetic camphor   sales are also significantly driven by growing demand for private-labelled camphorated medical products. For example, private labelled analgesic products have gained increased popularity in the US, as they are devoid of FDA approval, and witness strong promotion from retailer businesses. A key factor restricting adoption is regulations on the use of synthetic camphor in pharmaceutical products, such as the US FDA’s classification of cer...